New balloon treatment shows promise for long heart blockages
NCT ID NCT05471245
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special balloon coated with sirolimus, a drug that helps prevent arteries from narrowing again after angioplasty. It included 110 adults with stable or unstable coronary artery disease who had long blockages (at least 25 mm) in their heart arteries. The main goals were to measure how well the artery stayed open after 9 months and to track any serious heart problems like heart attacks or the need for another procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AULSS 2 Marca Trevigiana Ospedale di Conegliano
Conegliano, Italy/TV, 31015, Italy
-
Centro Cardiologico Monzino
Milan, Italy/MI, 20138, Italy
-
IRCCS Ospedale Galeazzi Sant'Ambrogio
Milan, Italy/MI, 20157, Italy
-
IRCCS Ospedale San Raffaele
Milan, Italy/MI, 20132, Italy
-
Istituto Clinico Humanitas
Rozzano, Italy/MI, 20089, Italy
-
Policlinico Tor Vergata
Rome, Italy/RM, 00133, Italy
-
Policlinico Universitario Campus Bio-Medico
Roma, Italy/RM, 00128, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?